ylliX - Online Advertising Network
Company Ticker News

PAOG RespRx CBD Pharmaceutical Respiratory Treatment In The Spotlight

PAOG RespRx CBD Pharmaceutical Respiratory Treatment In The Spotlight

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

SANDUSKY, Ohio, Oct. 14, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory treatment research. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No.

...read full article on PRNewsWire

ylliX - Online Advertising Network